Showing results (1721-1730 of 1,823) with videos related to
Sort By:
Pageof 183
Transplantation and Cellular Therapy|April 6, 2024
Evaluation of Circulating Endothelial Cells as Direct Marker of Endothelial Damage in Allo-Transplant Recipients at High Risk of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction SyndromeMirko Farina, Maria Chiara Scaini, Antonella Facchinetti, et al.Transplantation and Cellular Therapy|March 8, 2024
Defining and Grading Infections in Clinical Trials Involving Hematopoietic Cell Transplantation: A Report From the BMT CTN Infectious Disease Technical CommitteeZainab Shahid, Aaron M Etra, John E Levine, et al.Transplantation and Cellular Therapy|March 7, 2024
Umbilical Cord Blood Transplantation for Fanconi Anemia With a Special Focus on Late Complications: a Study on Behalf of Eurocord and SAAWP-EBMTHanadi Rafii, Fernanda Volt, Marc Bierings, et al.Transplantation and Cellular Therapy|March 13, 2024
Treatment-Sensitive and Treatment-Dependent Chronic Graft-versus-Host Disease Yield Superior Failure-Free and Overall Survival Compared to Treatment-Resistant Chronic Graft-versus-Host DiseaseNajla El Jurdi, Shannon Herzog, Ryan Shanley, et al.Transplantation and Cellular Therapy|March 9, 2024
Phase II Study of Allogeneic Hematopoietic Stem Cell Transplantation for Children with High-Risk Neuroblastoma Using a Reduced-Intensity Conditioning Regimen: Results from the AIEOP TrialArcangelo Prete, Edoardo Lanino, Francesco Saglio, et al.Transplantation and Cellular Therapy|July 12, 2024
Autologous Stem Cell Transplant in Fit Patients With Late Relapsed Diffuse Large B-Cell Lymphoma That Responded to Salvage ChemotherapyAung M Tun, Yucai Wang, Seth Maliske, et al.Transplantation and Cellular Therapy|July 12, 2024
Verification of the Prediction Accuracy of a Biomarker-Based Prognostic for Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) After Hematopoietic Cell Transplantation (HCT)Santosh Putta, Bradford Young, Polly Pine, et al.Transplantation and Cellular Therapy|July 11, 2024
Haploidentical Versus Mismatched Unrelated Donor Hematopoietic Cell Transplantation: HLA Factors and Donor Age ConsiderationsRohtesh S Mehta, Effie W Petersdorf, Tao Wang, et al.Transplantation and Cellular Therapy|June 30, 2024
Dermatologic Adverse Events Associated With Chimeric Antigen Receptor T-Cell Therapy: A Pharmacovigilance Analysis of the FDA Reporting SystemRyan Storgard, Stephen Dusza, Roni Shouval, et al.Transplantation and Cellular Therapy|March 28, 2024
Fully Human Anti-CD19 CAR T Cells Derived from Systemic Lupus Erythematosus Patients Exhibit Cytotoxicity with Reduced Inflammatory Cytokine ProductionJanin Dingfelder, Michael Aigner, Jule Taubmann, et al.Pageof 183